Scroll up
Incubatees in Programme
  • Novus Life Sciences Limited

    Unit 502, 5/F, Biotech Centre 1 No. 9 Sicence Park West Avenue Hong Kong Sicence Park


    NOVUS is a young and energetic biotech and medical research start-up established in 2014 by three young graduates of the University of Hong Kong. In an attempt to bridge the gap between the industry and academic institutions, NOVUS established itself as the bridge between industry and institutions to accelerate the commercialization process and put cutting edge technology into application. Based in Hong Kong Science Park, Novus is a member company of Incu-Bio Programme of HKSTPC. Novus focuses in the research, development and commercialization of orthobiologics and actively looking for opportunities in the wider life sciences sector. In 2014, NOVUS was named the finalist of Global Entrepreneurship Week (GEW 50) and CNBC’s 20 world’s hottest start-ups.


    NOVUS focuses on the development of orthobiologics and aims to fill a market gap with its technology by providing highly injectable biomaterial needed for minimal invasive surgical procedures, leaving no trace with minimal complexity in operation and patient downtime. The profitability is promising as the potential market of orthobiologics is enormous and it is still growing around the globe.

    Contact Person

    Wong Wilson